Source citationAgarwal R, Filippatos G, Pitt B, et al. Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis. Eur Heart J. 2022;43:474-84. 35023547.
Annals of internal medicine
University of Oxford, Oxford, Oxfordshire, England, UK (K.J.M., W.G.H.).
Kidney, Humans, Diabetes Mellitus, Type 2, Naphthyridines, Renal Insufficiency, Chronic